文献速递生殖医学母胎医学

囊胚培养液游离DNA能否替代胚胎活检用于植入前遗传学检测:系统综述

Is cell-free DNA in spent embryo culture medium an alternative to embryo biopsy for preimplantation genetic testing? A systematic review.
PubMed 文献 · Reprod Biomed Online · 2020-02-20

该系统综述汇总了以废弃培养液(SCM)中游离DNA进行非侵入性植入前遗传学检测(PGT)的已发表证据,指出SCM有望成为胚胎DNA的替代来源,并具有评估IVF胚胎遗传状态的诊断潜力;但其临床应用可靠性尚待确定,文中还讨论了优化与标准化流程以避免技术偏倚,并展望了在生殖医学中的应用前景。

要点

  • SCM中可检测到游离DNA,提示其作为非侵入性PGT胚胎DNA来源的潜力。
  • 侵入性PGT在胚胎嵌合体情况下可能导致遗传误诊,存在选错胚胎或销毁健康胚胎的风险。
  • SCM-based PGT的临床可靠性尚未确定,需优化和标准化流程以减少技术偏倚。

核心结论

  • SCM中游离DNA是非侵入性PGT的潜在胚胎DNA替代来源,但其临床应用可靠性仍需确定。

研究设计与样本

  • 系统综述,汇总已发表的关于基于废弃培养液(SCM)的非侵入性PGT证据。

主要发现

  • 越来越多的研究报告在SCM中检测到游离DNA,并强调其用于评估IVF胚胎遗传状态的诊断潜力。
  • 侵入性PGT在胚胎嵌合体情况下可能导致遗传误诊,进而选择受影响胚胎植入或销毁健康胚胎。

临床怎么用

  • 目前SCM-based PGT尚不宜替代侵入性PGT用于临床决策,需先优化和标准化流程以提升可靠性。

局限性

  • SCM-based PGT的临床可靠性尚未确定,现有证据存在技术偏倚风险,需未来研究改进性能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Preimplantation genetic testing (PGT) is increasingly used worldwide. It currently entails the use of invasive techniques, i.e. polar body, blastomere, trophectoderm biopsy or blastocentesis, to obtain embryonic DNA, with major technical limitations and ethical issues. Evidence suggests that invasive PGT can lead to genetic misdiagnosis in the case of embryo mosaicism, and, consequently, to the selection of affected embryos for implantation or to the destruction of healthy embryos. Recently, spent culture medium (SCM) has been proposed as an alternative source of embryonic DNA. An increasing number of studies have reported the detection of cell-free DNA in SCM and highlighted the diagnostic potential of non-invasive SCM-based PGT for assessing the genetic status of preimplantation human embryos obtained by IVF. The reliability of this approach for clinical applications, however, needs to be determined. In this systematic review, published evidence on non-invasive SCM-based PGT is presented, and its current benefits and limitations compared with invasive PGT. Then, ways of optimizing and standardizing procedures for non-invasive SCM-based PGT to prevent technical biases and to improve performance in future studies are discussed. Finally, clinical perspectives of non-invasive PGT are presented and its future applications in reproductive medicine highlighted.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Brouillet S, Martinez G, Coutton C, et al. Is cell-free DNA in spent embryo culture medium an alternative to embryo biopsy for preimplantation genetic testing? A systematic review. Reprod Biomed Online. 2020. PMID: 32417199. doi:10.1016/j.rbmo.2020.02.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。